INCRUSE ELLIPTA vs SPIRIVA RESPIMAT

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. INCRUSE ELLIPTA and SPIRIVA RESPIMAT are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	INCRUSE ELLIPTA	SPIRIVA RESPIMAT
Rating	New	72/100
Pharmacy pays	—	~$353.74 /30
Type	RX	RX
Active ingredient	UMECLIDINIUM BROMIDE	TIOTROPIUM BROMIDE
Manufacturer	Glaxo Grp England	Boehringer Ingelheim
Dosage forms	Spray/Inhaler	Spray/Inhaler, metered
Drug class	—	Anticholinergic
Boxed warning	None	None
Treats	Pulmonary Emphysema, Chronic Bronchitis	Pulmonary Emphysema, Chronic Bronchitis

incruse ellipta spiriva respimat

Rating

New

72/100

Pharmacy pays

—

~$353.74 /30

Type

Active ingredient

UMECLIDINIUM BROMIDE

TIOTROPIUM BROMIDE

Manufacturer

Glaxo Grp England

Boehringer Ingelheim

Dosage forms

Spray/Inhaler

Spray/Inhaler, metered

Drug class

—

Anticholinergic

Boxed warning

None

Treats

Pulmonary Emphysema, Chronic Bronchitis

Frequently asked questions

What is the difference between Incruse Ellipta and Spiriva Respimat?

Incruse Ellipta contains Umeclidinium Bromide, while Spiriva Respimat contains Tiotropium Bromide — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.